396 related articles for article (PubMed ID: 26973395)
1. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.
Gao J; Wang SH; Ding XM; Sun WB; Li XL; Xin ZH; Ning CM; Guo SG
World J Gastroenterol; 2015 May; 21(17):5287-94. PubMed ID: 25954102
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
[TBL] [Abstract][Full Text] [Related]
6. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices.
Zhang K; Jiang L; Jia Z; Zhang Y; He R; Ding Z; Mu Y
Dig Dis Sci; 2015 May; 60(5):1490-501. PubMed ID: 25431044
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
13. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.
Toshikuni N; Takuma Y; Goto T; Yamamoto H
Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175
[TBL] [Abstract][Full Text] [Related]
16. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
[TBL] [Abstract][Full Text] [Related]
17. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
[TBL] [Abstract][Full Text] [Related]
20. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
